A B S T R A C T The occurrence of circulating immune complexes was investigated in 31 patients with cytomegalovirus infection (29 infected in utero and 2 with natal infection) and 34 uninfected controls. Anticomplementary activity above 1:20 occurred in 34% (29/86) of the sera tested from the infected group in contrast to 7.5% (3/40) in the controls (P < 0.005). When assayed by means of a lymphoblastoid cell line (Raji cell test), the reactivity in these groups was 45 (39/86) and 2.7% (1/36), respectively (P < 0.001). Correlation of results between these two complement-dependent assays occurred in 75% of samples collected from the infected group. Frequency of reactivity was higher in severe intrauterine infection and during the 1st yr of life paralleling the patterns of viral excretion and humoral immune responses. Physicochemical characterization demonstrated that reactive substances in sera were acid-dissociable and, in one sample tested, contained 7S IgG antibodies with cytomegalovirus (CMV) specificity. Circulating immune complexes were heavier (18-22S) in sick, as opposed to subclinically CMV-infected patients, in whom intermediate size complexes (12-16S) were found. In three of four symptomatic patients whose demise was due to severe congenital infection, granular deposits of immunoglobulins and C3 were detected in a pattern typical of immune complexes along the glomerular basal membrane of the glomeruli. Whether or not circulation and deposition of heavier immune complexes contributed to the adverse clinical outcome is unresolved. Because of the high incidence of both congenital and natal CMV infections, definition of the pathogenetic potentials of both heavy and intermediate size immune complexes is required to design more effective therapeutic measures.
A B S T R A C T The occurrence of circulating immune complexes was investigated in 31 patients with cytomegalovirus infection (29 infected in utero and 2 with natal infection) and 34 uninfected controls. Anticomplementary activity above 1:20 occurred in 34% (29/86 ) of the sera tested from the infected group in contrast to 7.5% (3/40) in the controls (P < 0.005). When assayed by means of a lymphoblastoid cell line (Raji cell test), the reactivity in these groups was 45 (39/86) and 2 .7% (1/36), respectively (P < 0.001). Correlation of results between these two complement-dependent assays occurred in 75% of samples collected from the infected group. Frequency of reactivity was higher in severe intrauterine infection and during the 1st yr of life paralleling the patterns of viral excretion and humoral immune responses. Physicochemical characterization demonstrated that reactive substances in sera were acid-dissociable and, in one sample tested, contained 7S IgG antibodies with cytomegalovirus (CMV) specificity. Circulating immune complexes were heavier (18-22S) in sick, as opposed to subclinically CMV-infected patients, in whom intermediate size complexes (12-16S) were found. In three of four symptomatic patients whose demise was due to severe congenital infection, granular deposits of immunoglobulins and C3 were detected in a pattern typical of immune complexes along the glomerular basal membrane of the glomeruli. Whether or not circulation and deposition of heavier immune complexes contributed to the adverse clinical outcome is unresolved. Because of the high incidence of both congenital and natal CMV infections, definition of the pathogenetic potentials of both heavy and intermediate size immune complexes is required to design more effective therapeutic measures. INTRODUCTION Cytomegaloviruses (CMV)1 are the leading cause of congenital infections ofman with rates ranging from 0.5 to 2.4% of all live-births (1) (2) (3) . CMV may also be acquired by an additional 3-5% of neonates and young infants via exposure to maternal genital tract secretions, breast milk, and household contacts (4) . Fortunately, disease is rare with intrauterine infection and virtually lacking with natal or early postnatal acquisitions. Overt disease, with prominent involvement of reticuloendothelium, brain, and perceptual organs leading inevitably to debilitating sequelae, occurs in <5% of infants infected in utero. However, as recently shown, significant numbers of the remaining 95% subclinically infected at birth, manifest late-appearing injury, namely sensorineural hearing defects and decreased mentation (reviewed in reference 5). Perhaps this should not be surprising because CMV, when prenatally acquired, produces a chronic infection lasting several years. Persistent viral replication occurs in salivary gland and renal parenchyma as demonstrated by excretion of infectious virus in urine and saliva (6) . Likely viral replication also persists in other sites inaccessible to routine virologic examination. Congenital CMV infection, is also characterized by an apparent overstimulation of the humoral immune system as exemplified by accelerated postnatal development of serum IgM and IgG as compared to uninfected controls (7) . Though immunoglobulin development only grossly gauges antigenic load, it provides an indirect means for estimating the magnitude of the persistent antigenic stimulation associated with prenatally acquired CMV infection. More importantly, the specific humoral immune responses elicited are substantial and prolonged, whether the infection is productive or latent. (6) The persistence of viral excretion in the face of an overstimulated host immune responses provides a setting in which immune complex formation is highly probable. In fact, preliminary evidence suggests their occurrence in congenital and natal CMV infections (8, 9) . Defining the formation of immune complexes and their relative amounts, size, and physiochemical nature is important in assessing their possible role in the pathogenesis of disease, both acute and long term, especially with the intrauterine form of CMV infection.
In the present study, circulating immune complexes of intermediate size were encountered in patients with subclinical congenital CMV infection. In contrast, symptomatic patients circulated immune complexes of higher molecular size, and in three patients who died with severe disease deposits of IgG, IgM and C3 were demonstrated in the basal membrane of the glomeruli.
METHODS
Patients. We studied 31 patients with CMV infection and 34 uninfected controls. 29 were infected in utero, and 2 had natal CMV infection acquired via exposure to an infected maternal birth canal. Specific diagnosis was established as previously described (6) . Eight congenitally infected patients were symptomatic at birth, their main clinical manifestations being hepatosplenomegaly, jaundice, and thrombocytopenia. As a consequence ofthe severity ofthe infection, four ofthese patients died, three during the first 2 wk of life and the fourth at 8 mo ofage. The remaining 23, including the 2 with natally acquired CMV, had a subclinical infection at birth.
Sera. From CMV-infected patients, 109 sera were collected at preselected intervals from birth up to 8 yr. 56 samples were obtained during the 1st yr oflife. From the control group, 48 samples were available, 41 of which were also collected during the 1st yr after delivery. All sera tested had been stored at -20°C for varying periods ranging from 1 to 7 yr, the great majority for <1-2 yr.
Anticomplementary activity test. Sera were assayed for their ability to consume in vitro total hemolytic complement by a modification of the microcomplement fixation method of Wasserman and Levine (10) . Before testing, sera were heatinactivated at 56°C for 30 min. Veronal-buffered saline containing 0.15 mM Ca++, 1.0 mM Mg++, and 0.1% gelatin, ionic strength 0.147, pH 7.3, was used throughout. For initial screening purposes, 0.5 ml of a 1:10 dilution of each serum was incubated overnight at 40C with 1.2-1.5 CH50 U of human complement (0.5 ml). Optimally sensitized sheep erythrocytes (2.5 x 107 in 0.5 ml) were then added, and the samples were incubated for 90 min at 37°C. 2 ml ofnormal saline was then added, and after centrifugation the percent lysis was calculated spectrophotometrically (410 nm) from the amount of hemoglobin released in the supernate. Anticomplementary activity of positive sera was subsequently quantitated. The reciprocal of the dilution resulting in consumption of half of the available complement was judged as the end point in titrations.
Raji cell test. This assay was performed as described by Theofilopoulos et al. (11) . The Raji cells were grown as continuous cell lines in RPMI 1640 medium with 20% fetal calf serum. Cell viability was determined by trypan blue exclu- Sucrose density ultracentrifugation. Linear sucrose density gradients were prepared either in Veronal-buffered saline, pH 7.3, or in acetate buffer, pH 4.0. Centrifugation proceeded for 18 h at 35,000 rpm at 4°C in a Beckman model L ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) with a swinging SW 50 L rotor. 0.2 ml of sera was layered over the gradients equilibrated to 4°C. 0.2 ml-serial fractions were collected from the top of the 4-ml gradients by means of an ISCO fractionator (model 640, Instrumentation Specialties Co., Inc., Lincoln, Neb.). Human albumin, IgG, and IgM quantitated by radial immunodiffusion on the fractions obtained from a control normal human serum included in each run served as the 5S, 7S, and 19S markers, respectively.
Gel filtration. Gel filtration was performed by layering 2 ml of serum on a 0.7 x 100.0-cm Sephadex G-200 column (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) equilibrated with 0.1 M Tris-HCl, 0.2 M NaCl buffer, pH 8.0. 2-ml fractions were collected. Protein concentrations were determined by the Folin-Ciocalteu method (12) .
Immunofluorescent (IF) antibody test. CMV-specific antibodies present in sera or fractions were determined by the indirect IF assay for the late antigens of CMV (AD-169 strain), as previously described (6) . A 1:100 dilution of a FITC-conjugated goat anti-human Fc-IgG (fluorescein to protein ratio of 3 and a protein concentration of 1 mg/ml) prepared in this laboratory was employed. Before testing, all fractions that were collected from the acetate buffer pH 4.0 gradients were neutralized to pH 7.2 with 2 M Tris buffer. The feasibility of antibody measurements on these fractions by the IF method was demonstrated when the antibody levels of two positive control sera were shown to be similar before and after an 18-h incubation at 4°C in a 1:4 dilution of acetate buffer, pH 4.0.
Immunoglobulin quantification and immunoelectrophoresis. Levels of IgG and IgM used as sedimentation markers were determined by radial immunodiffusion (13) . Immunoelectrophoresis was performed in 0.5% agarose in 0.05 M Veronal buffer, pH 8.2 (14) .
Immunohistopathology. From three patients with fatal infection, portions of kidney tissue obtained at autopsy were prepared by fixation in 95% cold ethanol followed by paraffin embedding according to the method of SainteMarie (15) and by snap freezing at -70°C in O.C.T. compound (Ames Lab-Tek Products, Div. of Miles Laboratories, Elkhart, Ind.) (16 (21) . Briefly, tissue sections mounted on glass slides were first incubated with the human serum that provided our source of anti-CMV antibodies. After heat inactivation (56°C, 30 min) this serum had a 1:256 titer of complement-fixing antibodies to CMV as determined by the serologic ACIF assay. After incubation for 1 h at 37°C, followed by thorough washing in phosphate-buffered saline, tissue sections were incubated for a similar period with a 1:10 dilution of fresh normal human serum lacking antibodies to CMV, varicella-zoster (20) , and Epstein-Barr (19) viruses which provided the source of complement. The binding of C3 to the specific antigen-antibody complexes which locate in the infected cells was sought out with FITCconjugated goat anti-human C3/C3c at a dilution of 1:30. Controls of specificity for this procedure included incubation of tissue sections with serum lacking CMV antibodies, heat inactivation of the complement source, blocking with unconjugated anti-C3/C3c antibody, and the use of tissue sections of kidneys obtained from uninfected infants who died of unrelated causes.
RESULTS
Anticomplementary activity. As shown in Fig. 1 , levels of anticomplementary (AC) activity above 1:20 were detected in 29 of 86 sera (34%) collected from the CMV-infected infants as opposed to 3 of 40 sera (7.5%) obtained from the uninfected controls (P < 0.005). More importantly, 14 of the 18 infected patients tested had at least one sample with elevated AC levels in contrast to only 3 of the 26 uninfected controls (P < 0.001). Increased AC activity in the infected group was primarily detectable in sera collected during the 1st yr after delivery with 20 of 40 samples having levels of 1:20 or greater compared to 9 of 46 for those obtained afterwards (P < 0.001).
Raji cell test. 86 sera from the CMV-infected group were examined by this method. 1-3+ positive results were obtained in 39 samples (45%). In contrast, only 1 of 36 (2.7%) samples obtained from the uninfected controls were reactive (P < 0.001). 18 of 27 (66%) sera obtained from the eight symptomatic patients were found positive as opposed to 21 of 59 (35%) sera collected from subjects with subclinical infection (P < 0.02). Like AC activity, Raji cell reactivity was age-related. 66% (29/44) of the sera collected during the 1st yr after delivery were positive whereas only 28% of sera obtained at later ages were reactive. Among symptomatic infected patients, positive results were obtained on 13 Table I . Concordance between assays was 75% using sera from the infected group and 90% with control samples. Despite this strong correlation, Raji cell test results were positive on 10 sera from the infected group when insignificant (titer < 1:20) AC activity was detected and negative on six sera with elevated titers (>1:20).
Physicochemical characterization of circulating immune complexes. From infants with subclinical congenital CMV infection, two sera reactive in the Raji cell test with AC titers of 1:68 and 1:76 were examined by ultracentrifugal analyses in neutral (pH 7.3) and acid (pH 4.0) gradients. Results from the examination of one of these sera are summarized in Fig. 2 . After fractionation at neutral pH, AC and Raji cell reactivities were present in fractions corresponding to the 12-16S area of the gradients. However, both reactions disappeared or were markedly diminished after ultracentrifugation in acid gradients. As noted in Fig. 2 , comparative analyses of the distribution of specific CMV antibody in the fractions suggested dissociation of IgG antibody from intermediate size complexes. Peak antibody levels found in the 12-14S areas of the neutral gradients shifted toward the lighter 7S region after ultracentrifugation in acid gradients. Single serum samples with high levels (-1:10) Raji cell reactivity collected from four infants with severe cytomegalic inclusion disease were similarly examined for evidence of immune complexes by ultracentrifugal analyses. To avoid heat inactivation, only the Raji cell assay was employed to assess fractions. In contrast to sera collected from infants with subclinical infection, Raji cell reactivity was found in the heavier, 18-22S fractions ofthe neutral gradients but similarly disappeared (three sera) or was markedly diminished (one sera) after ultracentrifugation in acid gradients.
To better characterize the putative heavy complexes in sera obtained from sick infants, further purification and concentration steps were employed using one sample. The serum was first filtered through a Sephadex G-200 column. As shown in Fig. 3 , after this separation, Raji cell reactivity was confined to fractions from the void volume of the column whereas CMV-specific antibody was present in fractions constituting the second and major protein peak containing IgG. Fractions 28-32 of the void volume containing Raji cell but lacking specific CMV antibody activity were pooled and concentrated 10-fold by negative pressure. 0.2 ml of the concentrate was then subjected to (Fig. 5) , IgM, and C3 distributed in "lumpy-bumpy" patterns typical of immune complexes. After pretreatment of tissue sections with 2 M NaCl or pH 2.4 glycine buffer for 30 min, glomerular deposits of immunoglobulins and complement were no longer detectable. Attempts at demonstrating CMV antigens in similar location were not successful either before or after elution with similar buffers.
RTojitCell ------------------------_ _ _
In an attempt to define further whether the immune deposits were filtered from the circulation and trapped in the glomeruli or whether they represented CMV antibody attached to infected cells, the distribution of viral cellular antigens in the kidney sections were sought employing the more sensitive ACIF assay. Specific fluorescent staining occurred primarily in the renal tubular cells (Fig. 6 ). There was a remarkable contrast between the very bright staining ofthe tubular cells and the faint granular fluorescence of the glomerular basal membrane (Fig. 6) FIGuRE 6 Photomicrograph of renal glomerulus and tubules stained for CMV antigens by the method ofACIF. The kidney section obtained from a fatal case of congenital CMV infection was mounted on a glass slide and incubated with heat-inactivated human serum. This serum had a 1:256 titer of complement-fixing antibodies to CMV and lacked antibodies to Epstein-Barr, varicella-zoster, and herpes simplex type II viruses. After 1 h at 37°C, followed by thorough washing in phosphate-buffered saline, the tissue section was incubated for a similar period with a 1:10 dilution of fresh normal human serum lacking antibodies to CMV (complement source). The binding of C3 to viral antigen-antibody complexes was sought out with fluoresceinconjugated antiserum to human C3/C3c. Specific fluorescent staining is located primarily in the renal tubular cells. There is a remarkable difference between the very bright staining of tubular epithelium and the faint granular fluorescence of the glomerular basal membrane. Controls of specificity included incubation of similar tissue sections with serum lacking CMV antibodies, heat inactivation of the complement source, blocking with unconjugated antiserum to human C3/C3c, and the use of kidney sections from uninfected infants who died of unrelated causes.
for the understanding of immune complex-mediated disease in perinatal infections has been provided recently by mouse models of lymphocytic choriomeningitis and murine-CMV infections (22-24).
As evidenced here, during the 1st yr after delivery, immune complexes apparently circulate in a significant proportion of infants congenitally infected by CMV and may occur with natal acquisition as well. Frequency increases with the severity of intrauterine infection. Within the very limited number of observations made thus far, the complexes appear to be heavier (-18-22S) in sick, as opposed to asymptomatically infected, infants, in whom intermediate size complexes (12-16S) were found. Because of their larger size with severe disease, tissue deposition may occur as demonstrated in the renal glomeruli. Conclusions concerning frequency are based mainly in the high incidence of AC and Raji cell reactivity in sera of infected infants when compared to controls. One or both reactions occurred in two-thirds of all infants and one-third of all sera tested.
Exactly why antigen-antibody complexing should occur with greater facility during the 1st yr after delivery in these persistent infections is unclear. However, indirect evidence using quantitative viral excretion from the urinary tract as a monitor of antigen production suggests a period in early life of relative antigen excess with intrauterine infection (6) . During the first 6 mo, congenitally infected infants excrete significantly higher levels of virus than those natally infected, and sick infants consistently produce more virus than the asymptomatic ones. The humoral immune system is most markedly stimulated during this same period, irrespective of the nature of the congenital infection and continues to be long after levels of viral excretion among the different varieties of infection equalize (6) (7) (8) (28, 29) . Warm reactive IgG anti-Blymphocyte antibodies could, however, cause confusion because, theoretically, they could be placentally transferred to the fetus, should they exist in the maternal circulation. 80% of the mothers of our study population were primiparous and therefore less prone to form lymphocyte antibodies which are stimulated primarily as a result of repeat pregnancies. In any event, such matemal antibodies should be found just as often in our control as in our infected infant population.
The possibility of anti-B-lymphocyte antibody production by the infant as a result of CMV infection has yet to be studied to our knowledge. Nevertheless, such an occurrence could not explain the excess AC activity seen in the infected population, and the concordance between this activity and positive Raji cell response make immune complex formation the most likely explanation for both.
The latter conclusion is further substantiated by the physiochemical characterization of the reactive substances in a few sera and immunologic studies of the kidney sections. (30) . Complexes formed in slight antigen excess are large (>19S), like those shown here in sick neonates and may lead to tissue injury by deposition in the glomeruli, choroid plexus, and blood vessels. Their accumulation at these sites occurs when the rate of deposition exceeds that of degradation and elimination. Whether this immunologically mediated mechanism contributes to the adverse clinical course of the severe and fatal cases with congenital CMV infection remains unresolved. In the past, little attention has been given to renal function because of the more obvious and hazardous involvement of the reticuloendothelial and central nervous systems. In fact, immune complexes might be even contributory to the pathology in these organ systems in fulminant infections. With subclinical infections signs or symptoms of immune complex disease, such as those seen in serum sickness, rheumatoid arthritis or systemic lupus erythematosus have not been encountered. Instead, mental deficiency and sensorineural hearing loss are more prominent along with persistence of virus excretion, measured in years (5, 31) . Conceivably, circulating immune complexes could contribute to this insidious, progressive organ disease by interfering with host defense mechanism or by direct tissue damage in concert with continued low level viral replication. Because of the high incidence of perinatal CMV infection, precise definition of pathogenetic mechanisms is mandatory to design more effective therapeutic measures than those currently being attempted. 
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